Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Aug 1;23(15):4155-4162.
doi: 10.1158/1078-0432.CCR-16-3027. Epub 2017 Jul 20.

Insurance Clearance for Early-Phase Oncology Clinical Trials Following the Affordable Care Act

Kenneth L Kehl  1 , Cheryl P Fullmer  2 , Siqing Fu  2 , Goldy C George  2 , Kenneth R Hess  3 , Filip Janku  2 , Daniel D Karp  2 , Shumei Kato  4 , Cynthia K Kizer  2 , Razelle Kurzrock  4 , Aung Naing  2 , Shubham Pant  2 , Sarina A Piha-Paul  2 , Vivek Subbiah  2 , Apostolia M Tsimberidou  2 , David S Hong  5
Affiliations

Insurance Clearance for Early-Phase Oncology Clinical Trials Following the Affordable Care Act

Kenneth L Kehl et al. Clin Cancer Res. .

Abstract

Purpose: The Affordable Care Act (ACA) required that private insurance plans allow clinical trial participation and cover standard-of-care costs, but the impact of this provision has not been well-characterized. We assessed rates of insurance clearance for trial participation within our large early-phase clinical trials program, before and after implementation of the requirement.Experimental Design: We analyzed the departmental database for the Clinical Center for Targeted Therapy (CCTT) at MD Anderson Cancer Center (Houston, TX). Among patients referred for sponsored trials, we described rates of insurance clearance and prolonged time to clearance (at least 14 days) from July 2012 to June 2013 (baseline), July 2013-December 2013 (following CCTT staffing changes in July 2103), and January 2014-June 2015 (following implementation of the ACA). We used multivariable logistic regression models to compare rates across these time periods.Results: We identified 2,404 referrals for insurance clearance. Among privately insured patients, insurance clearance rates were higher for those referred from January 2014 to June 2015 than for those referred from July 2012 to June 2013 (OR, 4.72; 95% CI, 2.96-7.51). There was no association between referral period and clearance rates for Medicare/Medicaid patients (P = 0.25). Referral from January 2014 to June 2015 was associated with lower rates of prolonged clearance among both privately insured (OR 0.57; 95% CI, 0.38-0.86) and Medicare/Medicaid patients (OR 0.39; 95% CI, 0.19-0.83).Conclusions: Within our large early-phase clinical trials program, insurance clearance rates among privately insured patients improved following implementation of the ACA's requirement for coverage of standard-of-care costs. Clin Cancer Res; 23(15); 4155-62. ©2017 AACR.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Derivation of Study Cohort
Figure 2
Figure 2. Rates of insurance clearance by time period and insurance type*
*Error bars represent 95% exact binomial confidence intervals [Table: see text]
Figure 3
Figure 3. Prolonged time to insurance clearance by time period and insurance type*
* Error bars represent 95% exact binomial confidence intervals [Table: see text]
See this image and copyright information in PMC

References

    1. Nass SJ, Moses HL, Mendelsohn J. J Natl Cancer Inst Committee on Cancer Clinical Trials and the NCI Cooperative Group Program. Institute of Medicine, National Academies Press; 2010. A national cancer clinical trials system for the 21st century: reinvigorating the NCI Cooperative Group Program. - PubMed
    1. Fouad MN, Lee JY, Catalano PJ, Vogt TM, Zafar SY, West DW, et al. Enrollment of patients with lung and colorectal cancers onto clinical trials. J Oncol Pract. 2013;9:e40–7. - PMC - PubMed
    1. Stewart JH, Bertoni AG, Staten JL, Levine EA, Gross CP. Participation in surgical oncology clinical trials: gender-, race/ethnicity-, and age-based disparities. Ann Surg Oncol. 2007;14:3328–34. - PubMed
    1. Kehl KL, Arora NK, Schrag D, Ayanian JZ, Clauser SB, Klabunde CN, et al. Discussions About Clinical Trials Among Patients With Newly Diagnosed Lung and Colorectal Cancer. J Natl Cancer Inst. 2014;106:1–9. - PMC - PubMed
    1. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA. 2004;291:2720–6. - PubMed

LinkOut - more resources